Cargando…
How should we define STAT3 as an oncogene and as a potential target for therapy?
Aberrant activation of the STAT3 transcription factor has been reported in a large group of tumors and a strong biological basis now defines this protein as an oncogenic driver. Consequently, STAT3 is considered to be a promising target in the field of cancer therapy. For its inhibition to result in...
Autores principales: | Sellier, Hélène, Rébillard, Amélie, Guette, Catherine, Barré, Benjamin, Coqueret, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772112/ https://www.ncbi.nlm.nih.gov/pubmed/24069560 http://dx.doi.org/10.4161/jkst.24716 |
Ejemplares similares
-
Circulating miRNAs as new activators of the JAK-STAT3 pathway
por: Lam, David, et al.
Publicado: (2013) -
STAT3 as a new autophagy regulator
por: Jonchère, Barbara, et al.
Publicado: (2013) -
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
por: Pouliquen, Daniel L., et al.
Publicado: (2022) -
Biomarkers of tumor invasiveness in proteomics (Review)
por: Pouliquen, Daniel L., et al.
Publicado: (2020) -
Curcumin Treatment Identifies Therapeutic Targets within Biomarkers of Liver Colonization by Highly Invasive Mesothelioma Cells—Potential Links with Sarcomas
por: Pouliquen, Daniel L., et al.
Publicado: (2020)